1170 / 1456
Conclusion
• DIBH implementation in lymphoma very succesful
• Protocol in lung cancer patients ongoing
• Clear dosimetric benefit, even when using VMAT/IMRT
• Ressource investment: the ”sore points” are
•
PET scanning time
•
IGRT
•
And even then, they remain very manageable !